News
INM
1.380
-3.50%
-0.050
Weekly Report: what happened at INM last week (0817-0821)?
Weekly Report · 5d ago
Weekly Report: what happened at INM last week (0810-0814)?
Weekly Report · 08/17 09:29
Weekly Report: what happened at INM last week (0803-0807)?
Weekly Report · 08/10 09:28
Weekly Report: what happened at INM last week (0727-0731)?
Weekly Report · 08/03 09:28
Weekly Report: what happened at INM last week (0720-0724)?
Weekly Report · 07/27 09:29
Mentari merger financing reshapes InMed Pharmaceuticals’ future
TipRanks · 07/22 20:49
InMed Pharmaceuticals Merger Partner Raises $200 Million To Boost Migraine Pipeline
Benzinga · 07/22 18:46
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 07/22 17:05
InMed Shares Rise Pre-Market On Mentari's $200 Million Financing Ahead Of Merger
NASDAQ · 07/22 12:16
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 07/22 12:05
*InMed: Financing, Based on Current Plans, Extends Mentari's Cash Runway Into 2029 and Through Phase 2a Readouts on Each of the 2 PACAP-targeted Lead Programs, Including MT-002 >INM
Dow Jones · 07/22 11:08
*Mentari Therapeutics Announces $200M Private Placement
Dow Jones · 07/22 11:02
Press Release: Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline
Dow Jones · 07/22 11:00
Weekly Report: what happened at INM last week (0713-0717)?
Weekly Report · 07/20 09:28
Artisan Mid Cap Fund Q2 2026 Performance Review
Seeking Alpha · 07/15 17:56
Weekly Report: what happened at INM last week (0706-0710)?
Weekly Report · 07/13 09:28
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 07/10 21:05
InMed amends merger terms, advances Mentari transition
TipRanks · 07/10 20:32
InMed Pharmaceuticals amends merger pact with Mentari Therapeutics
TipRanks · 07/06 23:05
InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4
Newsfile · 07/06 22:20
More
Webull provides a variety of real-time INM stock news. You can receive the latest news about Inmed Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About INM
InMed Pharmaceuticals Inc. is a pharmaceutical company. The Company develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is a small molecule drug candidate being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.